ZA896463B - Thrombus control agent - Google Patents

Thrombus control agent

Info

Publication number
ZA896463B
ZA896463B ZA896463A ZA896463A ZA896463B ZA 896463 B ZA896463 B ZA 896463B ZA 896463 A ZA896463 A ZA 896463A ZA 896463 A ZA896463 A ZA 896463A ZA 896463 B ZA896463 B ZA 896463B
Authority
ZA
South Africa
Prior art keywords
human
csf
control agent
thrombus control
thrombus
Prior art date
Application number
ZA896463A
Other languages
English (en)
Inventor
Koichiro Tsuji
Tsuji Koichiro
Masayoshi Ono
Ono Masayoshi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA896463B publication Critical patent/ZA896463B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Networks Using Active Elements (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA896463A 1988-08-24 1989-08-24 Thrombus control agent ZA896463B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21037688 1988-08-24

Publications (1)

Publication Number Publication Date
ZA896463B true ZA896463B (en) 1990-05-30

Family

ID=16588321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896463A ZA896463B (en) 1988-08-24 1989-08-24 Thrombus control agent

Country Status (8)

Country Link
US (1) US5202117A (fr)
EP (1) EP0355811B1 (fr)
KR (1) KR950003492B1 (fr)
AT (1) ATE97813T1 (fr)
CA (1) CA1339071C (fr)
DE (1) DE68911061T2 (fr)
IL (1) IL91423A (fr)
ZA (1) ZA896463B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
FR2693907B1 (fr) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
US5879794A (en) * 1994-08-25 1999-03-09 W. L. Gore & Associates, Inc. Adhesive-filler film composite
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO1998020528A1 (fr) 1996-11-08 1998-05-14 W.L. Gore & Associates, Inc. PROCEDE D'AMELIORATION DE LA FIABILITE DE SUPPORTS DE CIRCUITS MINCES EN AUGMENTANT LA Tg DU SUPPORT
WO1999044630A1 (fr) * 1998-03-06 1999-09-10 Chugai Seiyaku Kabushiki Kaisha Preparations exemptes de proteines
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US20020198150A1 (en) * 2001-06-07 2002-12-26 Ayelet Chajut Methods of using colony stimulating factors in the treatment of tissue damage and ischemia
AU2003261723A1 (en) 2002-08-27 2004-03-19 Takeda Chemical Industries, Ltd. Cxcr4 antagonist and use thereof
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
WO2008075371A2 (fr) 2006-12-21 2008-06-26 Biokine Therapeutics Ltd. Analogues peptidiques de t-140 présentant une activité superagoniste par rapport à cxcr4 destinés à une immunomodulation
MX344166B (es) 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.
CN102159230A (zh) 2008-07-23 2011-08-17 Ambrx公司 经修饰的牛g-csf多肽和其用途
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
BRPI1009663A2 (pt) 2009-06-14 2016-10-11 Biokine Therapeutics Ltd "método para elevação dos níveis plaquetários em um indivíduo com essa necessidade, método de inibição de hemorragia em um indivíduo que a necessite e composição farmacêutica"
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
EP2841084B1 (fr) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
US10786547B2 (en) 2015-07-16 2020-09-29 Biokine Therapeutics Ltd. Compositions, articles of manufacture and methods for treating cancer
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
KR950003492B1 (ko) 1995-04-13
AU625914B2 (en) 1992-07-16
ATE97813T1 (de) 1993-12-15
US5202117A (en) 1993-04-13
EP0355811B1 (fr) 1993-12-01
DE68911061D1 (de) 1994-01-13
IL91423A (en) 1995-06-29
KR900002800A (ko) 1990-03-23
DE68911061T2 (de) 1994-03-24
EP0355811A3 (fr) 1991-03-20
CA1339071C (fr) 1997-07-29
IL91423A0 (en) 1990-04-29
EP0355811A2 (fr) 1990-02-28
AU4014789A (en) 1990-03-01

Similar Documents

Publication Publication Date Title
ZA896463B (en) Thrombus control agent
AU3275689A (en) Process for stabilizing human albumin solutions and the solution obtained
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
ZA95679B (en) Products containing G-CSF and TNF binding protein
GR3025134T3 (en) Process for preparing a concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use
IL94582A0 (en) Preparation for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
GB8920228D0 (en) Fatty acid therapy
RU95113499A (ru) Способ повышения мочеотделения у человека, способ снижения уровней холестерина и липопротеинов низкой плотности, применение (+) доксазозина
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
ZA90600B (en) Treatment of leukocyte dysefunction with gm-csf
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
JPS6483020A (en) Medicinal composition for preventing or treating aids
AU3028589A (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
ZA864610B (en) Use of benzamido-azabicyclo compounds in the treatment of migraine,nausea,vomiting and cardiac arrhythmia
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
EP0212310A3 (en) Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia
GR3000751T3 (en) Tpa-containing medical composition and use thereof
GR3017672T3 (en) Therapeutic agent for diabetic gangrene.
EP0340933A3 (fr) Formules contenant de l'héparine
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
EP0312132A3 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
Ikić et al. Topical application of human leukocyte interferon in stasis ulcers and deep burns
CA2186752A1 (fr) Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps